Login

Francesco De Santis and Italfarmaco

Francesco De Santis enters in Italfarmaco in 1981 at the age of 25 and has been covering during his career the different positions of Managing Director, Director of the Board, President of Italfarmaco Spa and is President of Italfarmaco Holding. He has personally driven the foundation and internationalization process of all of the Group’s companies.

"A number of success factors, that are inherent to Italfarmaco’s identity, have allowed the company to maintain its growth in the past 10 years. First of all, it is a family company... able to establish long-term plans without being affected by the market’s ups and downs. In addition, Italfarmaco always remained committed to research and innovation..."
Francesco De Santis, Focus Reports, April 2009

"...Whereas Italfarmaco’s main driver is research, the second one is surely international expansion. A consistent share of the revenues generated is reinvested to fulfil global ambitions and conquer new markets..."
Francesco De Santis, Focus Reports, July 2009

Statements & Interviews »

Research in pharmaceutical field

Newly appointed nominations in Farmindustria: FDS relected Vice President
In order to nominate the new executive board for the two year period 2013-2015, Farmindustria’s associative meeting held in Rome on July the 3rd 2013 has relected Francesco De Santis Vice President and member of the chairmanship's committee (in all, five Vice Presidents take part in the committee).
Pharmakronos, 3 July 2013

New laboratories C4T, Tor Vergata Centre – Pharmaceutical Industry
The new research centre called C4T (Colosseum Combination Chemistry Centre for Technology) is the result of the joint venture between Italian pharmaceutical industries (among which Italfarmaco) and the University of Tor Vergata. C4T develops projects carried out in partnership with academic groups of excellence both on national and international levels and offers research services for some of the most important pharmaceutical firms active in Italy...
Pharmakronos, 18 May 2011

Press Reviews »

"... great attention to women’s health: a mission shared by pharmaceutical companies.
To promote social awareness on the risk factors linked to women’s health (not only on reproductive aspects but also on social roles). To support a female health wise culture and encourage awareness concerning principles of equity and equal opportunity. To stimulate research on the major pathologies concerning women’s universe and their social, political and economical consequences (to increase the value of scientific knowledge and spread appropriate information)..."
Francesco De Santis, Delegate of Farmindustria for Research
L'industria farmaceutica e l'equità di genere, Quaderni della SIF, 2009, vol.17.

Publications »

Copyright © 2011-2013 all right reserved Francesco De Santis